LOS ANGELES, August 14, 2024 – ImmPACT Bio USA Inc. (ImmPACT Bio), a clinical-stage biopharmaceutical company developing a new generation of cellular therapies that have the potential to bring transformational benefits to patients, today announced the appointment of Ian Somaiya to its board of directors. Mr. Somaiya, currently chief financial officer (CFO) of NewAmsterdam Pharma Company […]
You are about to leave Immpact Bio's website to an external website.
Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.
You are about to leave Immpact Bio's website to an external website.
Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.
You are about to leave Immpact Bio's website to an external website.
Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.
You are about to leave Immpact Bio's website to an external website.
Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.
ImmPACT Bio is now part of Lyell Immunopharma
If you have a question about a clinical trial, please contact us at info@immpact-bio.com
